RECENT FUNDING
  1. Recent Funding
  2. Companies
  3. Arkuda Therapeutics

Arkuda Therapeutics

Leveraging new insights into progranulin and lysosomal biology to discover therapies to change the trajectory of neurodegenerative disease.

Latest funding

$64M Series B+ ·

Led by Cormorant Asset Management · Source: fundraisingfox.com

Total raised: $108M across 2 sourced rounds

All 2 rounds ↓
X: @ArkudaTx · 238 followers.
LinkedIn: linkedin.com.
Category: Health and bio.
Sectors: Biotechnology, Health Care, Pharmaceutical, Therapeutics.
Stage: Series B+.
Based in: Watertown, United States.
Founded: 2023.
Total raised: $108M in 2 sourced rounds.
Last round: Feb 10, 2022 · 1,740 days ago.
Headcount: 11–50 employees.
On Recent Funding since: Oct 1, 2026.

Signals

X account@ArkudaTx · created May 18, 2018 (8 years old) · 238 followers
Website registeredFeb 20, 2018 (8 years old)
TIMELINE · MONEY RAISED

Arkuda Therapeutics | 625 days from website to first raise on record

@ArkudaTx·Raised $108M in 2 sourced rounds·2 signals before the first raise
$27M$54M$81M$108MMARMAYJULSEPNOVJAN 2024MARMAY$108M||WEBSITE CREATED · FEB 20, 2018||X ACCOUNT CREATED @ARKUDATX · MAY 18, 2018$44M Series A · Nov 7, 2019$44M A · NOV '19$64M Series B+ · Feb 10, 2022$64M B+ · FEB '22

Money raised, round by round (amounts linked to their source). Pins are dated signals; hover the icons for dates.

Funding rounds

DateRoundAmountLeadSource
Series B+$64MCCormorant Asset Managementfundraisingfox.com
Series A$44MAAtlas Ventureprnewswire.com

Timeline

  1. X account created
  2. Website created

Founders and team

Investors

Companies like Arkuda Therapeutics

Other companies backed by Cormorant Asset Management

Cormorant Asset Management portfolio →

Sources and API

Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/arkuda-therapeutics (get a free API key).

Top raises, every week

The week's top funded startups and market insights, in your inbox every Monday.

Unsubscribe anytime · privacy